Cherwell passes Quality Assurance audits
Meeting BSI ISO 9001:2008 and measuring up to GMP
Cherwell Laboratories is among the first to receive BSI ISO 9001:2008 accreditation. The rapid attainment of this key new Quality Management Standard confirms Cherwell’s commitment to developing and improving its own quality processes to maintain full compliance within the regulatory world, according to the company.
In order to meet the quality demands of the pharmaceutical industry, every batch of media shipped by Cherwell is individually certificated in line with Pharmacopoeia requirements. Growth promotion and fertility tests undertaken within Cherwell’s own quality assurance laboratories validate the performance of every batch of media via a detailed Quality Control certificate. This confirms that specific media products will enable the growth of the correct microorganisms for that particular media formulation.
Further highlighting its commitment to quality, Cherwell has also recently undergone a number of successful quality assurance audits by some of its major pharmaceutical customers. Such audits require that Cherwell’s own standards measure up to the GMP (Good Manufacturing Practice) standards that are required of the pharmaceutical companies themselves by the MHRA (Medicines and Healthcare products Regulatory Agency).
“We are extremely pleased to be able to so successfully demonstrate the quality of our products, facilities and customer service,” said Andy Whittard, Managing Director at Cherwell Laboratories. “The Redipor brand has certainly built a strong reputation within the pharmaceutical industry for high quality products and a flexible, efficient service. Indeed, all our products are manufactured under the control of the ISO9001:2008 registered Quality Management system. At the core of this system is a desire to continually improve the quality of products and service offered. This can definitely be demonstrated by the high degree of positive feedback from our recent customer satisfaction survey.”
Other news from the department politics & laws
Most read news
More news from our other portals
Last viewed contents
Evolva reaches first milestone in Roquette collaboration
Are autoantibodies in COVID-19 less harmful than previously thought? - In most cases they are likely not to blame when patients become severely ill
Compugen Announces Diagnostic Biomarker Collaboration
Árpád_Pusztai
Antisoma's AS1413 gains FDA Fast Track status for treatment of secondary acute myeloid leukaemia
List_of_diseases_(T)
Co-trimoxazole
The NUVISAN group acquires a pre-clinical unit in Grafing from Merck - New Managing Director at the Grafing site
AMSBIO and Chondrex Cooperate On Arthritis & Inflammation Research
Microbes could help reduce the need for chemical fertilizers - A coating protects nitrogen-fixing bacteria: Start-up to commercialise coated bacteria for large-scale use in regenerative agriculture
How old memories fade away - Discovery of a gene essential for memory extinction could lead to new PTSD treatments
